Rusfertide for Polycythemia Vera: Incremental Benefit Assessment

Authors

Institutions

Publication Details

Journal
American Journal of Hematology
Published
2026-10-17
DOI
https://doi.org/10.1002/ajh.70528
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rusfertide for Polycythemia Vera: Incremental Benefit Assessment

Naseema Gangat, Paola Guglielmelli, Ayalew Tefferi, Alessandro Maria Vannucchi et al.
American Journal of Hematology
Myeloproliferative Neoplasms: Diagnosis and Treatment
article

Rusfertide for Polycythemia Vera: Incremental Benefit Assessment

Naseema Gangat, Paola Guglielmelli, Ayalew Tefferi, Alessandro Maria Vannucchi, Tiziano Barbui
article en

Abstract

No abstract available for this paper.
American Journal of Hematology
Mayo Clinic (US), Ospedale Papa Giovanni XXIII (IT), Azienda Ospedaliero-Universitaria Careggi (IT), FROM – Fondazione per la Ricerca Ospedale di Bergamo ETS (IT), University of Florence (IT)
Good health and well-being
Openalex Percentile: Top 13%
Myeloproliferative Neoplasms: Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.